NDC11 60505014108
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 60505-0141-08 | 60505-0141 |
| 60505-0141-8 | 60505-0141 |
| 60505-141-08 | 60505-141 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glipizide | GLIPIZIDE | Apotex Corp. | dcf426b8-bcdc-8214-a1b6-6388bd3399a0 | 2026-09-11 | Warnings, Adverse reactions | 60505-0141-8 60505-0141 60505014108 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.